MACK DAVID J.

CIK 00016944664 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001694466

Recent Transactions

32 trades

Award
BioXcel Therapeutics, Inc.$BTAI
Stock Option (Right to Buy)
2026-01-09+17,000→ 17,000 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-10-31−1,694→ 0 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-10-31+1,694→ 20,317 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-09-30−1,694→ 1,694 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-09-30+1,694→ 18,623 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-08-31+1,693→ 16,930 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-08-31−1,693→ 3,387 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-07-31+1,693→ 15,237 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-07-31−1,693→ 5,080 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-06-30−1,693→ 6,773 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-06-30+1,693→ 13,544 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-05-31−1,693→ 8,466 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-05-31+1,693→ 11,851 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-04-30+1,693→ 10,158 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-04-30−1,693→ 10,159 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-03-31+1,693→ 8,465 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-03-31−1,693→ 11,852 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-02-28−1,693→ 13,545 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-02-28+1,693→ 6,772 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-01-31−27,089→ 243,810 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-01-31+27,089→ 81,267 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-31+27,089→ 54,178 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-12-31+27,089→ 270,899 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-11-30−27,089→ 297,988 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-11-30+27,089→ 27,089 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-11-30+27,089→ 27,089 total
Award
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-11-21+297,988→ 297,998 total
Award
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-11-21+325,077→ 325,077 total
Other
TERRAFORM GLOBAL, INC.
Restricted Stock Units (Class A common stock)
2017-12-28−12,081→ 0 total
Disposition to Issuer
TERRAFORM GLOBAL, INC.
Restricted Stock Units (Class A common stock)
2017-12-28$5.10/sh−55,419→ 12,081 total
Award
TERRAFORM GLOBAL, INC.
Restricted Stock Units (Class A common stock)
2017-08-04+30,000→ 67,500 total
Award
TERRAFORM GLOBAL, INC.
Restricted Stock Units (Class A common stock)
2017-01-04+37,500→ 37,500 total

Companies

Recent Filings

Address

410 PARK AVENUE, SUITE 900

NEW YORK, NY, 10022

View on SEC.gov